Optimal management of severe symptomatic gastroesophageal reflux disease
NJ Talley, M Zand Irani - Journal of Internal Medicine, 2021 - Wiley Online Library
Gastroesophageal reflux disease (GERD) is a common disorder, and empirical proton pump
inhibitor (PPI) treatment is often the first step of management; however, up to 40% of patients …
inhibitor (PPI) treatment is often the first step of management; however, up to 40% of patients …
Optimal management of severe symptomatic gastroesophageal reflux disease
NJ Talley, MZ Irani - Journal of internal medicine, 2021 - pubmed.ncbi.nlm.nih.gov
Gastroesophageal reflux disease (GERD) is a common disorder, and empirical proton pump
inhibitor (PPI) treatment is often the first step of management; however, up to 40% of patients …
inhibitor (PPI) treatment is often the first step of management; however, up to 40% of patients …
Optimal management of severe symptomatic gastroesophageal reflux disease.
NJ Talley - Journal of Internal Medicine, 2020 - europepmc.org
Gastroesophageal reflux disease (GERD) is a common disorder, and empirical proton pump
inhibitor (PPI) treatment is often the first step of management; however, up to 40% of patients …
inhibitor (PPI) treatment is often the first step of management; however, up to 40% of patients …